✦ LIBER ✦

Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy

✍ Scribed by J. D. Bitran; R. K. Desser; C. M. Shapiro; A. Michel; M. F. Kozloff; A. A. Billings; W. Recent

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 382 KB
Volume: 51
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830201)51:3<381::aid-cncr2820510304>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 1 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3

Efficacy of bone and liver scanning in b

Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy

✍ Nelson B. Arnstein; John C. Harbert; Patrick J. Byrne 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

Predicting response to adjuvant and radi

Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma

✍ Harry B. Burke; Albert Hoang; J. Dirk Iglehart; Jeffrey R. Marks 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Background: Screening and surveillance is increasing the detection of early stage breast carcinoma. the ability to predict accurately the response to adjuvant therapy (chemotherapy or tamoxifen therapy) or postlumpectomy radiation therapy in these patients can be vital to their survival, because

The prognostic significance of sialyl-tn

The prognostic significance of sialyl-tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy

✍ Anita Yeomans Kinney; Aysegul Sahin; Sally W. Vernon; Ralph F. Frankowski; John 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Results . Forty-eight (23%) of the 207 specimens demonstrated high STn staining ter, Houston, Texas. (ú25% cells were immunoreactive). During a median follow-up of 5 years, high STn patients had worse disease free survival than low STn patients (55% vs. 74%,

Effect of adjuvant chemotherapy on outco

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy

✍ Jean-Yves Pierga; Bernard Asselain; Michel Jouve; Véronique Diéras; Mathieu Cart 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## BACKGROUND. The objective of the current study was to analyze the impact of adjuvant chemotherapy in comparison with other prognostic parameters on the outcome of a series of patients with breast carcinoma at time of metastatic recurrence. ## METHODS. Data from 1430 patients accrued in 8 pro

Response to second-line chemotherapy in

Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment : Prognostic factors

✍ Bernard Brun; Mohamed Benchalal; Christelle Lebas; Pascal Piedbois; Ma Lin; Jean 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

tic factors associated with response to a second-line chemotherapy in patients with metastatic breast carcinoma (MBC) that was previously responsive to a first-